Experienced in Polymyalgia Rheumatica

Dr. Kathleen P. Flint

Rheumatology
Articularis Healthcare Group Inc
1711 Saint Julian Pl, 
Columbia, SC 
 (4679.8 mi)
Accepting New Patients
Experienced in Polymyalgia Rheumatica
Articularis Healthcare Group Inc
1711 Saint Julian Pl, 
Columbia, SC 
 (4679.8 mi)
OverviewInsuranceLocationsClinical Research

Overview

Kathleen Flint is a Rheumatologist in Columbia, South Carolina. Dr. Flint and is rated as an Experienced provider by MediFind in the treatment of Polymyalgia Rheumatica. Her top areas of expertise are Rheumatoid Arthritis (RA), Psoriatic Arthritis, Psoriasis, and Antisynthetase Syndrome. Dr. Flint is currently accepting new patients.

Her clinical research consists of participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Internal Medicine in SC
Hospital Affiliations
Newberry County Memorial Hospital
Lexington Medical Center
Languages Spoken
English
Gender
Female

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Cigna
  •  Blue Cross Blue Shield
  •  Humana

Locations

ARTICULARIS HEALTHCARE GROUP INC
1711 Saint Julian Pl, Columbia, SC 29204

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: June 13, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: June 17, 2020
Intervention Type: Drug
Study Phase: Phase 3
A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis
A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: March 13, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: November 19, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials
Similar Doctors
Distinguished in Polymyalgia Rheumatica
Dr. Bruce E. Goeckeritz
Rheumatology
Distinguished in Polymyalgia Rheumatica
Dr. Bruce E. Goeckeritz
Rheumatology

Lexington Health Inc

146 E Hospital Dr, Suite 550, 
West Columbia, SC 
 (6.4 mi)
803-936-7410
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Bruce Goeckeritz is a Rheumatologist in West Columbia, South Carolina. Dr. Goeckeritz and is rated as a Distinguished provider by MediFind in the treatment of Polymyalgia Rheumatica. His top areas of expertise are Rheumatoid Arthritis (RA), Juvenile Temporal Arteritis, Behcet Disease, and Giant Cell Arteritis (GCA). Dr. Goeckeritz is currently accepting new patients.

Advanced in Polymyalgia Rheumatica
Dr. Frederick A. Talip
Rheumatology
Advanced in Polymyalgia Rheumatica
Dr. Frederick A. Talip
Rheumatology

Lexington Health Inc

146 E Hospital Dr, Suite 550, 
West Columbia, SC 
 (6.4 mi)
803-936-7410
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Frederick Talip is a Rheumatologist in West Columbia, South Carolina. Dr. Talip and is rated as an Advanced provider by MediFind in the treatment of Polymyalgia Rheumatica. His top areas of expertise are Rhizomelic Pseudopolyarthritis, Polymyalgia Rheumatica, Gout, and Bursitis. Dr. Talip is currently accepting new patients.

Advanced in Polymyalgia Rheumatica
Dr. Mark H. Greenberg
Rheumatology
Advanced in Polymyalgia Rheumatica
Dr. Mark H. Greenberg
Rheumatology
2 Medical Park Rd Ste 501, 
Columbia, SC 
 (6.3 mi)
803-540-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Mark Greenberg is a Rheumatologist in Columbia, South Carolina. Dr. Greenberg and is rated as an Advanced provider by MediFind in the treatment of Polymyalgia Rheumatica. His top areas of expertise are Temporal Arteritis, Giant Cell Arteritis (GCA), Juvenile Temporal Arteritis, and Necrotizing Vasculitis. Dr. Greenberg is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile